The 2020 Hepatitis C Global Progress Report "includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pharmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings." It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.